Who is sponsoring NCT00377000?

NCT00377000 is sponsored by Sanofi.

What condition does NCT00377000 study?

NCT00377000 studies Acne Vulgaris.

What drugs are being tested in NCT00377000?

Interventions: clindamycin 1% / benzoyl peroxide 5% gel pump, clindamycin 1% / benzoyl peroxide 5% tube.

What is the status of NCT00377000?

NCT00377000 is currently COMPLETED.

Last reviewed 2007-10-05 · How we verify

A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.

NCT00377000 Phase 4 COMPLETED

Evaluate patient preference factors comparing two clindamycin/benzoyl peroxide gels. One dispensed in a pump presentation, the other in a tube presentation.

Details

Lead sponsor	Sanofi
Phase	Phase 4
Status	COMPLETED
Enrolment	60
Start date	2005-11
Completion	2006-03

Conditions

Acne Vulgaris

Interventions

clindamycin 1% / benzoyl peroxide 5% gel pump
clindamycin 1% / benzoyl peroxide 5% tube

Primary outcomes

Patient Preference Questionnaire evaluation: including product use, patient knowledge and impression of acne, as well as patient treatment
The incidence of all adverse events reported during the study will be summarized by treatment group
The signs and symptoms of irritation will be summarized descriptively by treatment group at every visit
Investigator irritation grading - erythema, peeling, dryness and pruritus at Baseline (Week 0), Week 2, 4, and 6